LOS ANGELES, Feb. 23, 2004 (PRIMEZONE) -- IPOdesktop.com presents "BioSante CEO Interview" a web radio interview with Stephen M. Simes, CEO of BioSante Pharmaceuticals, Inc. (AMEX:BPA).
CEO guest: Stephen M. Simes, CEO of BioSante Pharmaceuticals Show host: Francis Gaskins, Editor, http://IPOdesktop.com
CLICK-TO-LISTEN -- includes 30-second preview http://www.worldtalkradio.com/archive.asp?aid=1184 (If this is not a direct link simply copy & paste to your browser) at WorldTalkRadio.com, the largest Internet Talk station (Finance & Investments, CEO interviews)
Forward Looking Statements: http://gaskinsco.com/forwardlooking.htm
About BioSante Pharmaceuticals, Inc.
BioSante is developing a pipeline of hormone therapy products to treat both men and women. BioSante also is developing its calcium phosphate nanotechnology (CAP) for novel vaccines, vaccine adjuvants and drug delivery systems. Additional information is available online at www.biosantepharma.com.